Barbara Sullivan, MD
Obstetrics & Gynecology · Jackson, MSNPI 1912934126
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,303 and has fallen 64.5% since, to $463 in 2025.
Across 262 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$979
- Mayne Pharma Commercial LLC$493
- Sumitomo Pharma America, Inc.$392
- Intuitive Surgical$330
- Takeda Pharmaceuticals U.S.A., Inc.$301
- Amgen$208
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,21293%
- Gifts$3307%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $979 |
| Mayne Pharma Commercial LLC | 35 | $493 |
| Sumitomo Pharma America, Inc. | 27 | $392 |
| Intuitive Surgical | 4 | $330 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $301 |
| Amgen | 13 | $208 |
| Pfizer | 11 | $177 |
| Gynesonics, Inc. | 1 | $141 |
| Shield Therapeutics Inc | 7 | $141 |
| Hologic Sales And Service, LLC | 7 | $128 |
| Coopersurgical, Inc. | 5 | $107 |
| Organon | 9 | $107 |
| Sage Therapeutics, LLC | 5 | $96 |
| Exeltis, USA Inc. | 5 | $77 |
| Daiichi Sankyo Inc. | 4 | $74 |
| Therapeuticsmd, Inc. | 4 | $64 |
| Lupin Inc. | 3 | $58 |
| Urovant Sciences Inc | 3 | $52 |
| AstraZeneca | 3 | $48 |
| Bayer | 3 | $47 |
| Innovation Technologies Inc | 1 | $41 |
| Zyla Life Sciences, Inc. | 3 | $40 |
| Evofem Biosciences, Inc. | 3 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| BD | 1 | $38 |
| Avion Pharmaceuticals | 3 | $38 |
| Nalpropion Pharmaceuticals LLC | 3 | $37 |
| Astellas Pharma US Inc | 2 | $33 |
| Scynexis, Inc. | 2 | $31 |
| Myovant Sciences Inc. | 2 | $29 |
| Baxter Healthcare | 1 | $22 |
| Conmed Corporation | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Inari Medical, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Radius Health, Inc. | 1 | $11 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,542 in reported general payments places this provider in the 85th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 27 | $11,540 |
| Estradiol | 158 | $4,891 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $2,196 |
| DottiEstradiol | 18 | $1,660 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,363 |
| SynthroidLevothyroxine Sodium | 12 | $1,139 |
| ValacyclovirValacyclovir Hcl | 26 | $808 |
| ProgesteroneProgesterone, Micronized | 15 | $728 |
| Medroxyprogesterone Acetate | 29 | $432 |
| Metronidazole | 11 | $323 |
| Zolpidem Tartrate | 62 | $294 |
| Escitalopram Oxalate | 19 | $291 |
| Citalopram HbrCitalopram Hydrobromide | 30 | $273 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $235 |
| Atorvastatin Calcium | 24 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $177 | $11,54027 claims |
| AbbVieSynthroid | $979 | $1,13912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 318 obstetrics & gynecology providers in Mississippi.
Other obstetrics & gynecology in Jackson
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Fred IngramJackson$8K
- Jennifer MosesJackson$8K
- Kathryn JeromeJackson$8K
- John WooleyJackson$7K
- Erica OryJackson$6K
- Amanda NicolsJackson$6K
- Leland GebhartJackson$5K
- Meredith TravelsteadJackson$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.